Country: Australia
Bahasa: Inggeris
Sumber: Department of Health (Therapeutic Goods Administration)
Immunoglobulin - normal; human normal immunoglobulin
Grifols Australia Pty Ltd
Medicine Registered
CMI Flebogamma 10 DIF .doc 1 CONSUMER MEDICINE INFORMATION LEAFLET READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Flebogamma 10% DIF is and what it is used for 2. Before you use Flebogamma 10% DIF 3. How to use Flebogamma 10% DIF 4. Possible side effects 5. How to store Flebogamma 10% DIF 6. Further information 1. WHAT FLEBOGAMMA 10% DIF IS AND WHAT IT IS USED FOR WHAT FLEBOGAMMA 10% DIF IS Flebogamma 10% DIF is a solution for intravenous infusion containing 100 g/l human normal immunoglobulin. Flebogamma 10% DIF is one of the group of medicines called intravenous immunoglobulins. These are used to treat conditions where the body’s defence system against disease is not working properly. WHAT FLEBOGAMMA 10% DIF IS USED FOR Treatment of patients who do not have sufficient antibodies (replacement therapy): • Primary immunodeficiency syndromes such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia - common variable immunodeficiency - severe combined immunodeficiency - Wiskott Aldrich syndrome • Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. Treatment of patients with certain inflammatory disorders (immunomodulation): • Idiopat Baca dokumen lengkap
PI Flebogamma 10 DIF.doc 1/14 Product information FLEBOGAMMA 10% DIF NAME OF THE MEDICINE Flebogamma 10% DIF Human normal immunoglobulin (IVIg) 100 mg/ml - Solution for infusion DESCRIPTION Flebogamma 10% DIF (dual _ _ inactivation plus nanofiltration) (IVIg) is a sterile, clear or slightly opalescent and colourless to pale yellow, liquid ready to use, preparation of highly purified immunoglobulin (IgG) obtained from human plasma pools. The purification process includes cold alcohol fractionation, polyethylene glycol precipitation, ion exchange chromatography, low pH treatment, pasteurisation, solvent detergent treatment and two sequential nanofiltrations through 35 nm and 20 nm pore size nanofilters connected in series. Flebogamma 10% DIF is a highly purified (≥ 97% IgG), unmodified, human IgG that contains the antibody specificities found in the donor population. IgG subclasses are fully represented with the following approximate percents of total IgG: IgG 1 is 66.6%, IgG 2 , 27.9%, IgG 3 , 3.0%, and IgG 4 , 2.5%. Flebogamma 10% DIF contains only trace amounts of IgA (lower than 100 micrograms/ml). In the final formulation, Flebogamma 10% DIF contains 10 g human normal immunoglobulin and 5 g sorbitol (as stabiliser) in 100 ml of water for injections. There is no preservative in the formulation. The pH of the solution ranges from 5 to 6 and the osmolality from 250 to 350 mOsm/kg, which is within the normal physiologic range. The Fc and Fab functions are maintained in Flebogamma 10% DIF. PHARMACOLOGY PHARMACODYNAMIC PROPERT Baca dokumen lengkap